AI assistant
Sending…
ProPhase Labs, Inc. — Director's Dealing 2020
Aug 18, 2020
34999_dirs_2020-08-18_3a9896f4-c2e0-4242-882a-bfad0f2af0c7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ProPhase Labs, Inc. (PRPH)
CIK: 0000868278
Period of Report: 2020-08-16
Reporting Person: Brady Monica L. (Chief Financial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-08-16 | Option (right to buy) | $2.64 | A | 150000 | Acquired | 2027-08-16 | Common Stock (150000) | Direct |
Footnotes
F1: The transaction reported in this row involves a grant by the Issuer to the Reporting Person of options to purchase the Issuer's common stock that will vest in four equal annual installments beginning August 16, 2020, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of August 16, 2020.
More from ProPhase Labs, Inc.
Regulatory Filings
2026
Mar 27
Regulatory Filings
2026
Feb 13
Regulatory Filings
2026
Feb 13
Regulatory Filings
2026
Jan 27
Regulatory Filings
2026
Jan 23
Delisting Announcement
2026
Jan 23
Regulatory Filings
2026
Jan 23
Regulatory Filings
2026
Jan 9
Regulatory Filings
2026
Jan 9
Regulatory Filings
2026
Jan 2